News
AB Science's new Phase 3 trial of masitinib for ALS has been cleared to launch in certain European countries, as well as in ...
The ongoing EAP that is providing ALS patients with access to MN-166 (ibudilast) outside of a clinical trial is adding more ...
The ALS Association has announced the eight winners two new Hoffman award programs designed to improve access to ...
Columnist Kristin Neva shares what she feels has worked and not worked in terms of slowing her husband's ALS progression over 15 years.
The FDA approved an expanded access program for troculeucel, making the treatment available to patients outside clinical trials.
Caregivers can keep communication going for people living with ALS by using tools, patience, and clear language.
Columnist Kristin Neva says she's heard that some patients are being told they can't get feeding tubes until they have worsening problems.
China’s Center for Drug Evaluation (CDE) has approved a request by Zhimeng Biopharma to launch a Phase 2/3 study of its experimental therapy CB03-154 in people with amyotrophic lateral sclerosis (ALS) ...
ALS is challenging, but you are not alone: Our ALS community is here to support you with their tips, advice, and words of wisdom.
An electromyography (EMG) is one of the key tests in diagnosing amyotrophic lateral sclerosis (ALS). It is also referred to as "needle EMG" and is normally performed alongside nerve conduction studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results